News Release

Commercialization of nanotechnology

3rd in a series of nanotechnology reviews

Business Announcement

AZoNetwork

Nanotechnology Victoria (NanoVic) and AZoNetwork are pleased to release the third in a series of Nanotechnology Reviews in a Podcast format.

This third Podcast titled "Commercialization of Nanotechnology" features key stakeholders discussing the crucial issues around how nanotechnology can be taken from research and development and translated into successful commercial outcomes.

Dr Peter Binks, CEO of NanoVic (Melbourne) and podcast interviewee commented, "Nanotechnology has moved from the research laboratory into the domain of product development over the last two years. It is now an investment proposition, and faces the challenges of any new venture in an uncertain market.

This podcast is very timely. Five of the investment managers, advisors and portfolio managers give their candid views on what nanotechnology investments are like, and what features successful investments must have. This provides a useful perspective for anyone considering investment in this new field, or sponsoring a development trying to make its way in the market"

Dr Ian Birkby, the CEO of AZoNetwork (Sydney), the operator of the AZoNano.com website commented, "The commercialization of nanotechnology provides real opportunities but there are questions as to whether nanotechnology requires a different model. This podcast gives people considering commercialization real insights into different approaches and advice from players who are in different stages of the nanotechnology investment cycle."

The podcast features interviews with:

  • Dr Peter Binks, CEO of Nanotechnology Victoria (NanoVic) on the role NanoVic plays in their commercialization process and an insight into the role of governments in Australia;
  • Dr Greg Smith, founder of SciVentures, an early stage venture capital investor who is keen to see passion in the eyes of his investees;
  • Dr. Paul McCormack, CEO of Perth based Advanced Nanotechnology, on the experience of taking nanotechnology research from the laboratory at the University of Western Australia to a listing on the Australian Stock exchange;
  • Dr Calum Drummond, Chief of the Division of Materials Science and Engineering at the Australia Government laboratory CSIRO, on the process of spinning out knowledge and IP from CSIRO into CAP-XX, a world leading producer of super capacitors;
  • Dr John Kapeleris, Deputy CEO of the Australian Institute of Commercialisation on ways nanotechnology commercialisation can be supported; and
  • Ms Tina Rankovic, CEO of the Australian Nano Business Forum, on the outlook for the nanotechnology industry in Australia.

Click here to listen to the podcast in full

###

About AZoNetwork

AZoNetwork owns and operates The A to Z of Building, The A to Z of Materials, The A to Z of Nanotechnology, and the A to Z of medical news.

Based in Sydney Australia the company was founded in April 2000 and currently serves over 2.4 million monthly visitors sessions from the engineering, science, construction and medical sectors.

About Nanotechnology Victoria ( NanoVic)

Nanotechnology Victoria Ltd (Melbourne Australia) is a nanotechnology commercialization company with funding from the Victorian Government and contributions from RMIT, Swinburne University and Monash University. It has a portfolio of investments and licenses in nanomaterials and bionano developments, and is a leading contributor to education and public awareness of nanotechnology in Australia

For further information on the podcast please contact:

Dr. Kristin Alford
Director
Bridge8 Pty Ltd (for Nanotechnology Victoria)
PH: +61 410 442 629
Email (kristin@bridge8.com.au)

Dr Ian Birkby
CEO
AZoNetwork
PH: +61 2 9999 0070
Email (ianbirkby@azonetwork.com)


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.